Catherine Schulte
Stock Analyst at Baird
(2.18)
# 1233
Out of 5,218 analysts
125
Total ratings
62.63%
Success rate
15.58%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Mettler-Toledo Intl | Maintains: Neutral | 1375 1310 | 1278.78 | 2.44% | 6 | Nov 11, 2024 | |
Maravai LifeSciences | Maintains: Outperform | 10 9 | 5.67 | 58.73% | 4 | Nov 8, 2024 | |
Exact Sciences | Maintains: Outperform | 70 67 | 61.38 | 9.16% | 13 | Nov 6, 2024 | |
Bio-Techne | Maintains: Outperform | 82 84 | 75.59 | 11.13% | 8 | Oct 31, 2024 | |
Avantor | Maintains: Outperform | 27 26 | 22.32 | 16.49% | 10 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 632 622 | 527.13 | 18% | 25 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 278 277 | 235.01 | 17.87% | 6 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 49 52 | 45.37 | 14.61% | 2 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 147 136 | 139.07 | -2.21% | 14 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 182 165 | n/a | n/a | 6 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 42 38 | 28.83 | 31.81% | 7 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 56 33 | 47.54 | -30.58% | 3 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 4 2 | n/a | n/a | 1 | Jun 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 335 281 | 143.9 | 95.27% | 6 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 21 | n/a | n/a | 1 | May 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 35 29 | n/a | n/a | 5 | Apr 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 208 217 | 378.18 | -42.62% | 7 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 17 20 | 166.11 | -87.96% | 1 | Jun 28, 2018 |